Senior Specialist, Corporate Communications

Tonix Pharmaceuticals
* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg).

Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-Borrelia

OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit (Use the "Apply for this Job" box below). follow the Company on Linked Inand X .

* Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace Sym Touch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.

The Senior Specialist, Corporate Communications is responsible for supporting the strategy, development, and execution of a broad and highly active portfolio. Our communications initiatives include supporting business objectives, strengthening corporate reputation, raising corporate and executive visibility, cultivating employee engagement, and evolving the brand as we further our transition into a "commercial-stage" community. This dynamic role serves as a trusted communications partner, creating and delivering impactful messaging and materials across internal and external channels to reach a variety of audiences, including investors.

The position requires strong writing and editing, attention to detail, cross-functional and external stakeholder relationship building, collaboration, project management, brand management, and organization capabilities.

Draft, review, and/or secure approval on a range of materials, including messaging/corporate narrative, press releases, social media posts, bylined media articles and Q&As, thought leadership, multimedia, factsheets, website content, and more

Support communications for corporate, data, and regulatory newsflow

Serve as the day-to-day lead on managing the corporate website, including fielding cross-functional requests for updates

Manage the corporate brand by collaborating with teams on multi-purpose messaging and imagery requests for medical meetings, commercial booths and sponsor ships, patient advocacy initiatives, and corporate events

Interact closely with external public relations and website vendor partners to manage the accurate and timely delivery of a variety of projects for corporate and executive communications efforts

Fulfill ad-hoc requests related to materials development, benchmarking, performance metrics reporting, media monitoring, social listening, and more

Support materials development and execution for quarterly earnings, including on the press release, script, Q&A, deck, and live call

Serve in a supporting role on miscellaneous financial communications, including messaging, investor outreach notes, and banking conference presentations

Help with corporate presentation updates

Handle IR database entries to track meetings with the Street

Liaise with external investor relations vendor partners as needed on the website, newsflow, and other activities

Handle ad-hoc benchmarking and research requests to support communications